Northern Trust’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-300
| Closed | -$2.12K | – | 4535 |
|
|
2023
Q2 | $2.12K | Hold |
300
| – | – | ﹤0.01% | 4528 |
|
|
2023
Q1 | $8.43K | Buy |
300
+188
| +168% | +$9.15K | ﹤0.01% | 4539 |
|
|
2022
Q4 | $7.3K | Hold |
112
| – | – | ﹤0.01% | 4604 |
|
|
2022
Q3 | $27K | Hold |
112
| – | – | ﹤0.01% | 4491 |
|
|
2022
Q2 | $51K | Hold |
112
| – | – | ﹤0.01% | 4408 |
|
|
2022
Q1 | $99K | Hold |
112
| – | – | ﹤0.01% | 4339 |
|
|
2021
Q4 | $110K | Hold |
112
| – | – | ﹤0.01% | 4393 |
|
|
2021
Q3 | $179K | Buy |
112
+2
| +2% | +$3.27K | ﹤0.01% | 4225 |
|
|
2021
Q2 | $193K | Hold |
110
| – | – | ﹤0.01% | 4176 |
|
|
2021
Q1 | $233K | Buy |
110
+71
| +182% | +$174K | ﹤0.01% | 4060 |
|
|
2020
Q4 | $41K | Buy |
39
+23
| +144% | +$17.5K | ﹤0.01% | 4256 |
|
|
2020
Q3 | $11K | Sell |
16
-6
| -27% | -$5.63K | ﹤0.01% | 4257 |
|
|
2020
Q2 | $26K | Buy |
22
+8
| +57% | +$9.11K | ﹤0.01% | 4135 |
|
|
2020
Q1 | $14K | Hold |
14
| – | – | ﹤0.01% | 4128 |
|
|
2019
Q4 | $20K | Hold |
14
| – | – | ﹤0.01% | 4158 |
|
|
2019
Q3 | $34K | Hold |
14
| – | – | ﹤0.01% | 4097 |
|
|
2019
Q2 | $53K | Hold |
14
| – | – | ﹤0.01% | 4075 |
|
|
2019
Q1 | $86K | Buy |
14
+2
| +17% | +$9.71K | ﹤0.01% | 3949 |
|
|
2018
Q4 | $31K | Sell |
12
-1
| -8% | -$3.23K | ﹤0.01% | 4117 |
|
|
2018
Q3 | $66K | Hold |
13
| – | – | ﹤0.01% | 4092 |
|
|
2018
Q2 | $39K | Buy |
13
+4
| +44% | +$15.1K | ﹤0.01% | 4154 |
|
|
2018
Q1 | $46K | Hold |
9
| – | – | ﹤0.01% | 4089 |
|
|
2017
Q4 | $48K | Buy |
9
+1
| +13% | +$7.03K | ﹤0.01% | 4079 |
|
|
2017
Q3 | $59K | Hold |
8
| – | – | ﹤0.01% | 4040 |
|
|
2017
Q2 | $94K | Buy |
8
+1
| +14% | +$14.8K | ﹤0.01% | 3989 |
|
|
2017
Q1 | $126K | Sell |
7
-12
| -63% | -$218K | ﹤0.01% | 3907 |
|
|
2016
Q4 | $339K | Buy |
19
+11
| +138% | +$218K | ﹤0.01% | 3622 |
|
|
2016
Q3 | $170K | Buy |
8
+1
| +14% | +$17.8K | ﹤0.01% | 3781 |
|
|
2016
Q2 | $104K | Buy |
7
+1
| +17% | +$15.8K | ﹤0.01% | 3884 |
|
|
2016
Q1 | $91K | Hold |
6
| – | – | ﹤0.01% | 3928 |
|
|
2015
Q4 | $59K | Hold |
6
| – | – | ﹤0.01% | 4030 |
|
|
2015
Q3 | $62K | Buy |
6
+1
| +20% | +$18.6K | ﹤0.01% | 4024 |
|
|
2015
Q2 | $116K | Sell |
5
-1
| -17% | -$24.4K | ﹤0.01% | 3925 |
|
|
2015
Q1 | $151K | Hold |
6
| – | – | ﹤0.01% | 3938 |
|
|
2014
Q4 | $207K | Hold |
6
| – | – | ﹤0.01% | 3806 |
|
|
2014
Q3 | $196K | Sell |
6
-21
| -78% | -$594K | ﹤0.01% | 3841 |
|
|
2014
Q2 | $753K | Sell |
27
-7
| -21% | -$179K | ﹤0.01% | 3495 |
|
|
2014
Q1 | $1.01M | Sell |
34
-2
| -6% | -$69.8K | ﹤0.01% | 3396 |
|
|
2013
Q4 | $1.26M | Buy |
36
+1
| +3% | +$23.7K | ﹤0.01% | 3328 |
|
|
2013
Q3 | $834K | Buy |
35
+21
| +150% | +$677K | ﹤0.01% | 3372 |
|
|
2013
Q2 | $622K | Buy |
+14
| New | +$783K | ﹤0.01% | 3412 |
|
Other funds holding BIOL
AFM
ZF
TRCT
FDCDDQ
Northern Trust's BIOL Position: Q3 2023 in Review
Northern Trust sold out of Biolase, Inc. (BIOL) in Q3 2023, closing a stake of 300 shares — an estimated $2.12K sold.
Northern Trust first reported a position in BIOL in Q2 2013 and held it in 41 quarters. The position peaked at $1.26M in Q4 2013. 12 funds tracked by Wall St. Rank hold BIOL as of Q3 2023.
- Northern Trust reported no remaining Biolase, Inc. position as of Q3 2023 after selling out during the quarter.
- Northern Trust sold 300 Biolase, Inc. shares in Q3 2023, an estimated $2.12K.
- Northern Trust first reported a position in Biolase, Inc. in Q2 2013 and held it in 41 quarters.
- Northern Trust's Biolase, Inc. position peaked at $1.26M in Q4 2013.
- 12 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2023.
Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.